Statistics
| Views | |
|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 318 |
| October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
|---|---|---|---|---|---|---|---|
| Caracterización epidemiológica y molecular de aislamientos clínicos productores de carbapenemasas | 9 | 21 | 6 | 3 | 3 | 4 | 12 |
| Views | |
|---|---|
| TD_2019_debelder_011.pdf | 557 |
| Views | |
|---|---|
| Argentina | 78 |
| United States | 44 |
| Peru | 28 |
| Mexico | 24 |
| Spain | 15 |
| Colombia | 13 |
| Ecuador | 10 |
| Chile | 9 |
| Canada | 8 |
| Cuba | 8 |
| Views | |
|---|---|
| Buenos Aires | 19 |
| Lima | 17 |
| Mexico | 11 |
| Quito | 8 |
| Vancouver | 7 |
| Federal | 6 |
| La Habana | 5 |
| La Paz | 5 |
| Santiago | 5 |
| Falls Church | 4 |